Parkside Financial Bank & Trust’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $779 | Buy |
+22
| New | +$895 | ﹤0.01% | 2433 |
|
|
2025
Q4 | – | Sell |
-18
| Closed | -$848 | – | 2711 |
|
|
2025
Q3 | $848 | Sell |
18
-14
| -44% | -$726 | ﹤0.01% | 2354 |
|
|
2025
Q2 | $1.67K | Sell |
32
-31
| -49% | -$1.7K | ﹤0.01% | 2063 |
|
|
2025
Q1 | $3.81K | Buy |
63
+55
| +688% | +$3.54K | ﹤0.01% | 1716 |
|
|
2024
Q4 | $548 | Buy |
8
+3
| +60% | +$209 | ﹤0.01% | 1857 |
|
|
2024
Q3 | $360 | Buy |
5
+3
| +150% | +$212 | ﹤0.01% | 1894 |
|
|
2024
Q2 | $139 | Sell |
2
-23
| -92% | -$1.68K | ﹤0.01% | 1990 |
|
|
2024
Q1 | $2K | Buy |
25
+19
| +317% | +$1.69K | ﹤0.01% | 1515 |
|
|
2023
Q4 | $658 | Sell |
6
-72
| -92% | -$7.45K | ﹤0.01% | 1699 |
|
|
2023
Q3 | $7.87K | Hold |
78
| – | – | ﹤0.01% | 1199 |
|
|
2023
Q2 | $10.6K | Hold |
78
| – | – | ﹤0.01% | 1097 |
|
|
2023
Q1 | $8.1K | Buy |
78
+1
| +1% | +$97 | ﹤0.01% | 1176 |
|
|
2022
Q4 | $6.83K | Sell |
77
-20
| -21% | -$1.66K | ﹤0.01% | 1197 |
|
|
2022
Q3 | $8K | Sell |
97
-91
| -48% | -$8.58K | ﹤0.01% | 1047 |
|
|
2022
Q2 | $18K | Sell |
188
-6
| -3% | -$720 | 0.01% | 832 |
|
|
2022
Q1 | $29K | Hold |
194
| – | – | 0.01% | 719 |
|
|
2021
Q4 | $28K | Buy |
194
+103
| +113% | +$14.6K | 0.01% | 702 |
|
|
2021
Q3 | $12K | Buy |
91
+1
| +1% | +$131 | ﹤0.01% | 903 |
|
|
2021
Q2 | $12K | Buy |
90
+7
| +8% | +$958 | ﹤0.01% | 906 |
|
|
2021
Q1 | $11K | Hold |
83
| – | – | ﹤0.01% | 896 |
|
|
2020
Q4 | $9K | Buy |
83
+47
| +131% | +$4.45K | ﹤0.01% | 899 |
|
|
2020
Q3 | $3K | Buy |
36
+20
| +125% | +$1.63K | ﹤0.01% | 1033 |
|
|
2020
Q2 | $1K | Buy |
16
+5
| +45% | +$348 | ﹤0.01% | 1291 |
|
|
2020
Q1 | $1K | Sell |
11
-14
| -56% | -$1.29K | ﹤0.01% | 1228 |
|
|
2019
Q4 | $3K | Hold |
25
| – | – | ﹤0.01% | 1040 |
|
|
2019
Q3 | $2K | Buy |
25
+14
| +127% | +$1.31K | ﹤0.01% | 1130 |
|
|
2019
Q2 | $1K | Hold |
11
| – | – | ﹤0.01% | 1334 |
|
|
2019
Q1 | $1K | Sell |
11
-13
| -54% | -$945 | ﹤0.01% | 1298 |
|
|
2018
Q4 | $2K | Hold |
24
| – | – | ﹤0.01% | 1039 |
|
|
2018
Q3 | $2K | Hold |
24
| – | – | ﹤0.01% | 1056 |
|
|
2018
Q2 | $2K | Hold |
24
| – | – | ﹤0.01% | 1036 |
|
|
2018
Q1 | $2K | Buy |
24
+11
| +85% | +$657 | ﹤0.01% | 994 |
|
|
2017
Q4 | $1K | Hold |
13
| – | – | ﹤0.01% | 1096 |
|
|
2017
Q3 | $1K | Buy |
13
+6
| +86% | +$301 | ﹤0.01% | 1090 |
|
|
2017
Q2 | $0 | Buy |
+7
| New | +$346 | ﹤0.01% | 1427 |
|
|
2017
Q1 | – | Sell |
-15
| Closed | -$1K | – | 1379 |
|
|
2016
Q4 | $1K | Buy |
+15
| New | +$637 | ﹤0.01% | 1064 |
|
Other funds holding CNMD
CB
Parkside Financial Bank & Trust's CNMD Position: Q1 2026 in Review
Parkside Financial Bank & Trust opened a new position in CONMED (CNMD) in Q1 2026: 22 shares worth $779. The stake represents ﹤0.01% of the portfolio and ranks #2433 among its holdings. This is a return to the name: Parkside Financial Bank & Trust previously reported a position in CNMD as recently as Q3 2025.
Parkside Financial Bank & Trust first reported a position in CNMD in Q4 2016 and has held it in 36 quarters since. The position peaked at $29K in Q1 2022. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- Parkside Financial Bank & Trust held 22 shares of CONMED worth $779 as of Q1 2026.
- CONMED was a new Parkside Financial Bank & Trust position in Q1 2026.
- CONMED made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2433 holding.
- Parkside Financial Bank & Trust first reported a position in CONMED in Q4 2016 and has held it in 36 quarters since.
- Parkside Financial Bank & Trust's CONMED position peaked at $29K in Q1 2022.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.